NG Testa
- Hematology top 0.5%
- Hematopoietic Stem Cell Transplantation 35
- Acute Myeloid Leukemia Research 11
- Chronic Myeloid Leukemia Treatments 5
- Genetics top 1%
- Mesenchymal stem cell research 8
- Immunology top 5%
- Immune Cell Function and Interaction 5
- Oncology top 5%
- Cancer Cells and Metastasis 11
- Emergency Medicine top 5%
-
- Erythrocyte Function and Pathophysiology 8
-
- Acute Lymphoblastic Leukemia research 5
- Cited by
- HematologyGeneticsImmunology
- Journals
- Blood (15 papers)British Journal of Haematology (5 papers)British Journal of Cancer (5 papers)
- Partner nations
- United KingdomItalyGermany
In The Last Decade
NG Testa
65 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 86
- Hematology 1.5k
- Genetics 608
- Immunology 520
- Oncology 591
- Emergency Medicine 116
Countries citing papers authored by NG Testa
This map shows the geographic impact of NG Testa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NG Testa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NG Testa more than expected).
Fields of papers citing papers by NG Testa
This network shows the impact of papers produced by NG Testa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NG Testa. The network helps show where NG Testa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside NG Testa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 9 | |
| 2 | 1999 | 13 | |
| 3 | 1999 | 22 | |
| 4 | 1998 | 13 | |
| 5 | 1998 | 1 | |
| 6 | 1997 | 2 | |
| 7 | 1997 | 8 | |
| 8 | 1995 | 51 | |
| 9 | 1993 | 152 | |
| 10 | Peripheral blood progenitor cells PBPC for haemopoietic rescue for poor prognosis high grade NHL | 1992 | 1 |
| 11 | 1992 | 43 | |
| 12 | 1991 | 7 | |
| 13 | 1990 | 17 | |
| 14 | 1989 | 31 | |
| 15 | 1989 | 6 | |
| 16 | 1989 | 4 | |
| 17 | 1988 | 13 | |
| 18 | 1987 | 16 | |
| 19 | Long-term damage to haemopoietic subpopulations in mice after repeated treatment with BCNU or cyclophosphamide. | 1986 | 6 |
| 20 | 1981 | 26 |
About NG Testa
NG Testa is a scholar working on Hematology, Genetics and Immunology, having authored 65 papers that have together received 2.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (35 papers), Cancer Cells and Metastasis (11 papers), Acute Myeloid Leukemia Research (11 papers), Erythrocyte Function and Pathophysiology (8 papers), Mesenchymal stem cell research (8 papers), Immune Cell Function and Interaction (5 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (608 citations) and Immunology (520 citations). NG Testa has collaborated with scholars based in United Kingdom, Italy and Germany. Frequent co-authors include B. I. Lord, JH Hendry, TM Dexter, Ruth Pettengell, James Chang, D. Crowther, T. M. Dexter, Thomas Luft, JM Hows and John Radford. Their work appears in journals such as Blood, British Journal of Haematology, British Journal of Cancer, Radiotherapy and Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.